W u Guanjiang is a co-founder of Chongqing Zhifei Biological Products, one of China's largest private vaccine manufacturers. He served as the company's chairman during its formative years, guiding it through critical growth phases and its successful initial public offering on the Shenzhen Stock Exchange in 2010. Zhifei is known for distributing Merck's HPV vaccines in China as well as developing its own proprietary vaccines.
Over the years, Wu has gradually stepped back from the company's day-to-day operations and has sold a significant portion of his shares, diversifying his wealth. Although he no longer holds a management role and his stake has dipped below 5%, the proceeds from his equity sales have cemented his financial standing. He remains a notable figure in the history of China's biotech industry.
Advertisement
Wu Guanjiang is a Chinese businessman, a cofounder of Chongqing Zhifei Biological Products (SZSE: 300122), a major vaccine maker.
Wu, who was previously chairman, has since gradually reduced his stake in the company and no longer has a management role. His wealth is primarily comprised of the proceeds from the sale of his shares over the years.
Wu Guanjiang's career is defined by his foundational role in establishing one of China's leading vaccine manufacturers. His structural achievement is tied to co-founding Zhifei, which successfully listed on the Shenzhen Stock Exchange in 2010.
Following the company's public offering, Wu progressively divested his holdings. His fortune is secured by these liquid assets, as he gradually reduced his stake to less than 5% and no longer has a management role.
Advertisement
Cofounded Chongqing Zhifei Biological Products and served as chairman.
Zhifei listed on the Shenzhen Stock Exchange.
Gradually reduced his stake and exited management.
Wu Guanjiang's wealth is concentrated in the liquid proceeds from the sale of his founding equity in the publicly traded pharmaceutical giant, Chongqing Zhifei Biological Products.
Advertisement
Advertisement
No publicly available quotes.
Advertisement
+0.81% | +$86.70M
+0.21% | +$2.85M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content